Medera
Biotechnology Research • 
Boston, Massachusetts, United States • 11-20 Employees
Company overview
| Headquarters | 6 Tide St, 2nd Floor, Boston, Massachusetts 02210, US |
| Phone number | +16174758541 |
| Websites | |
| NAICS | 541714 |
| Employees | 11-20 |
| Socials |
Key Contact at Medera
Suresh Pullela
Vice President Operations Quality, Sardocor Corp
Medera Email Formats
Medera uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@medera-biopharm.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@medera-biopharm.com | 100% |
About Medera
Founded in 2014, Medera is a clinical-stage company dedicated to next-generation cell and gene therapies for difficult-to-treat and incurable diseases. Medera’s preclinical and clinical programs target a range of cardiac, vascular and muscular indications, including Heart Failure with preserved Ejection Fraction (HFpEF), Duchenne Muscular Dystrophy and Pulmonary Hypertension, etc. Medera operates via its 2 subsidiaries: Novoheart (www.linkedin.com/company/novoheart-limited) is responsible for Disease Modelling & Drug Discovery using our proprietary, award-winning mini-Heart Technology, which offers a range of bioengineered human heart constructs including the world’s first human heart-in-a-jar as healthy and diseased human hearts for testing toxicity and efficacy. This platform enables us to uniquely model human-specific diseases and discover therapeutic candidates all in the context of human cells and tissues, free from species-specific differences. Before privatisation by Medera, Novoheart was dually listed on the Toronto Stock Exchange and Frankfurt Stock Exchange. Sardocor (www.linkedin.com/company/sardocor) is dedicated to the clinical development of novel therapies. Building upon Novoheart’s bioengineered human tissue-based assays for disease modelling and drug discovery, Sardocor aspires to create the shortest regulatory path to the clinic for advancing effective next-generation cell & gene therapy.
Medera revenue & valuation
| Annual revenue | $1,625,545 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $5,300,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Medera has 7 employees across 4 departments.
Departments
Number of employees
Funding Data
Medera has never raised funding before.
Medera Tech Stack
Discover the technologies and tools that power Medera's digital infrastructure, from frameworks to analytics platforms.
Hosting
Reverse proxies
United Kingdom
Czechia
NetherlandsFrequently asked questions
4.8
40,000 users
